What is bupropion's potential in inducing Serotonin Syndrome (SS), a condition characterized by excessive levels of serotonin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bupropion's Potential in Inducing Serotonin Syndrome

Bupropion has minimal potential to cause serotonin syndrome when used alone at therapeutic doses, as it does not inhibit serotonin reuptake or monoamine oxidase, but can cause serotonin syndrome in overdose situations or when combined with other serotonergic medications. 1

Mechanism of Action and Serotonergic Properties

  • Bupropion primarily acts as a norepinephrine and dopamine reuptake inhibitor with minimal direct serotonergic effects 1
  • According to FDA labeling, bupropion "does not inhibit monoamine oxidase or the reuptake of serotonin" 1
  • Despite its minimal direct serotonergic activity, bupropion can contribute to serotonin syndrome through indirect mechanisms, particularly in overdose situations 2

Risk of Serotonin Syndrome with Bupropion

Monotherapy at Therapeutic Doses

  • When used alone at therapeutic doses, bupropion has a very low risk of causing serotonin syndrome 1
  • The FDA label does not list serotonin syndrome as a common adverse effect of bupropion monotherapy at therapeutic doses 1

Overdose Situations

  • In overdose, bupropion can cause serotonin toxicity even without other serotonergic medications 2
  • A retrospective study found that 33% of patients with isolated bupropion overdose developed serotonin toxicity meeting Hunter Criteria 2
  • The median dose associated with serotonin syndrome in overdose was 2,250 mg, significantly higher than therapeutic dosing 2
  • Case reports document serotonin syndrome in adolescents after single-agent bupropion overdose, with symptoms including hyperthermia, clonus, hyperreflexia, and agitation 3, 4

Combination with Other Serotonergic Medications

  • The risk of serotonin syndrome significantly increases when bupropion is combined with other serotonergic medications 5
  • Bupropion can inhibit CYP2D6, potentially increasing blood levels of SSRIs and other serotonergic medications, further increasing the risk 5
  • Case reports document serotonin syndrome when bupropion is combined with:
    • SSRIs such as sertraline 5
    • Other antidepressants like trazodone 6
    • Electroconvulsive therapy in patients on multiple psychotropic medications 6

Clinical Manifestations of Bupropion-Associated Serotonin Syndrome

  • Symptoms typically develop within 24-48 hours after combining medications or after overdose 7
  • Clinical presentation includes:
    • Mental status changes: confusion, agitation, anxiety 7
    • Neuromuscular hyperactivity: tremors, clonus, hyperreflexia, muscle rigidity 7
    • Autonomic hyperactivity: hypertension, tachycardia, tachypnea, diaphoresis, hyperthermia 7
  • Advanced symptoms may include fever, seizures, arrhythmias, and unconsciousness, which can be fatal 7

Management Considerations

  • Hospital-based treatment with discontinuation of all serotonergic agents 7
  • Supportive care with continuous cardiac monitoring 7
  • Case reports suggest cyproheptadine may be effective in treating bupropion-induced serotonin syndrome 3
  • Caution should be exercised when combining bupropion with other serotonergic medications 7
  • If combination therapy is necessary, start the second serotonergic drug at a low dose, increase slowly, and monitor closely, especially in the first 24-48 hours after dosage changes 7

Common Pitfalls and Caveats

  • Misdiagnosis of early serotonin syndrome symptoms as worsening of the underlying psychiatric condition 5
  • Failure to recognize bupropion as a potential contributor to serotonin syndrome, especially in overdose situations 2, 3
  • Underestimating the risk when combining bupropion with other medications that have serotonergic properties 5
  • Not considering bupropion's CYP2D6 inhibition, which can increase levels of other serotonergic medications 5

In conclusion, while bupropion alone at therapeutic doses carries minimal risk for serotonin syndrome, clinicians should be vigilant when prescribing it in combination with other serotonergic medications or when treating patients with bupropion overdose.

References

Research

Serotonin toxicity from isolated bupropion overdoses.

Clinical toxicology (Philadelphia, Pa.), 2020

Research

Bupropion induced serotonin syndrome: a case report.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.